Leyla Kragten-Tabatabaie has a background in Medical Biology and received her PhD in Metabolic diseases in children at the Wilhelmina Children’s Hospital, University Medical Center in Utrecht, The Netherlands. Leyla Kragten-Tabatabaie has been involved from the beginning with the inception, shaping and managing of ReSViNET and has a central role in all ReSViNET activities including communications with ReSViNET (scientific) board, involvement in clinical trials and related educational activities and organizing scientific conferences and masterclasses. She has set up and is the former project leader for the RSV GOLD study, is involved in the ReSViNET activities for the RESCEU study and plays a crucial role in all ReSViNET RSV studies regarding patient advisory board activities, peer-to-peer education for the site study team and overall communication lines between the sponsor, project manager and Principal investigator ensuring clinical trials are smoothly and efficiently rolled-out in the network.
